Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Colorectal cancer

R A Audisio¹, F de Braud, J Wils

¹European Institute of Oncology (IEO), Milano, Italy.

Critical Reviews in Oncology/Hematology

|May 8, 1998

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE study.

ESMO gastrointestinal oncology·2026

Same author

Angiogenesis and thymic epithelial tumors: from preclinical insights to different therapeutic lines and combination strategies.

Cancer treatment reviews·2025

Same author

Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).

ESMO open·2025

Same author

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Same author

Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Same author

PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers.

ESMO open·2022